Corpay (NYSE:CPAY) Hits New 52-Week High Following Analyst Upgrade
Corpay, Inc. (NYSE:CPAY – Get Free Report) shares reached a new 52-week high on Thursday after BMO Capital Markets raised their price target on the stock from $350.00 to $390.00. BMO Capital Markets currently has an outperform rating on the stock. Corpay traded as high as $320.19 and last traded at $319.40, with a volume […]
More Stories
Playtika Holding Corp. (NASDAQ:PLTK) Given Consensus Rating of “Hold” by Analysts
Playtika Holding Corp. (NASDAQ:PLTK – Get Free Report) has earned an average rating of “Hold” from the ten research firms...
Softchoice Co. (TSE:SFTC) Receives C$22.67 Consensus PT from Brokerages
Softchoice Co. (TSE:SFTC – Get Free Report) has received a consensus rating of “Hold” from the two analysts that are...
Brokerages Set Verastem, Inc. (NASDAQ:VSTM) Price Target at $13.00
Verastem, Inc. (NASDAQ:VSTM – Get Free Report) has been given an average rating of “Buy” by the nine brokerages that...
Snowflake (NYSE:SNOW) Price Target Raised to $208.00
Snowflake (NYSE:SNOW – Free Report) had its target price boosted by Piper Sandler from $185.00 to $208.00 in a research...
Truist Financial Cuts Ball (NYSE:BALL) Price Target to $73.00
Ball (NYSE:BALL – Free Report) had its price objective decreased by Truist Financial from $78.00 to $73.00 in a report...
Bank of America Cuts Neumora Therapeutics (NASDAQ:NMRA) Price Target to $7.00
Neumora Therapeutics (NASDAQ:NMRA – Free Report) had its price target reduced by Bank of America from $22.00 to $7.00 in...